Affiliation:
1. iGenetic Diagnostic- Trutest laboratory , Pune.
Abstract
COVID -19 infection is an ongoing pandemic. The world has already witness two waves and a third one is imminent. Also
the COVID 19 infection is now presenting with numerous manifestation besides respiratory symptom. Thus it becomes
essential to study surrogate markers or various biochemical and hematological parameters and their signicance in these cases.
Data available so far is mostly from other nations with only a limited number of studies from Indian context. Thus the present study was
conducted to evaluate the signicance of laboratory parameters in predicting cases infected with COVID 19 and also the correlation of these
parameters with gender and course of disease.
557 subjects were included in this study from Pune, Maharashtra. The groups were divided into cases and controls on basis of RT PCR results and
clinical manifestations. The control group had 442 subjects and the cases were 135 in number.
The inammatory markers (CRP, D-dimer and ferritin) were signicantly high in cases as compared to controls. Among cases 40 % patients
belonged to young age (<45 years), 38% to middle age (45 -59 years) and 22 % to elderly group (>60 years). This shows high infectivity rate in
st younger group as compared to 1 wave. NLR was higher in cases as compared to controls. CRP, D-dimer and ferritin were signicantly higher in
cases as compared to controls
Reference21 articles.
1. WHO | Pneumonia of unknown cause – China. WHO [Internet]. 2020 [cited 2020 Jul 7]; Available from: http://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/
2. New-type coronavirus causes pneumonia in Wuhan: expert - Xinhua | English.news.cn [Internet]. [cited 2020 Jul 7]. Available from: http://www.xinhuanet.com/english/2020-01/09/c_138690570.htm
3. Stop the Wuhan virus. Nature [Internet]. 2020 Jan 21 [cited 2020 Jul 7];577(7791):450–450. Available from: http://www.nature.com/articles/d41586-020-00153-x
4. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al; Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720.
5. Al Ghamdi M, Alghamdi KM, Ghandoora Y, Alzahrani A, Salah F, Alsulami A, et al. Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia. BMC infectious diseases. 2016;16(1):174